What is PT-141?
PT-141 (bremelanotide) is a melanocortin receptor agonist. Unlike vascular treatments, it acts on pathways in the nervous system related to sexual arousal, and is FDA-approved for hypoactive sexual desire disorder in some populations.
Also known as: Bremelanotide
Commonly researched for
Research status
FDA-approved for a specific indication.
Important considerations
Prescription medication. Can affect blood pressure; medical supervision advised.